‹ ›
MYP_038644
← PREVIOUS NEXT → BACK
Basic Information
LCB1
Antimicrobial
Antiviral
Antiviral ▸ Anti-Coronavirus ▸ Anti-SARS-CoV-2
Enzyme modulation ▸ Enzyme inhibition ▸ Binding inhibition
Membrane / Ion-channel modulation ▸ Sodium channel modulation ▸ Sodium channel inhibitor
Standard
56 amino acids
C301H485N79O94S3
Standard
Sequence
DKEWILQKIYEIMRLLDELGHAEASMRVSDLIYEFMKKGDERLLEEAERLLEEVER
Physicochemical Analysis
6810.74 Da
4.59
-7.12
-7.41
-0.1272
-0.57
0.85
-0.15
21.55
106.25
0.0714
8480.00
8480.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
2842.68
-17.26
99.0
91.0
243.0
477.0
6.0
56.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0054098 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral
SARS-CoV-2
PMID32907861 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/32907861/
RECORD: Rec_0114970 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Anti-SARS-CoV-2
Virus:SARS-CoV-2:Inhibition of infection in Vero E6 cells
0.000024 μM
IC50
PMID32907861 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/32907861/
RECORD: Rec_0191850 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protein-derived synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-SARS-CoV-2 Binding inhibition
SARS-CoV-2 | E6 cells
0.00002354 μM
IC50
Mammalian: 1.1 h; Yeast: 3 min; E. coli: >10 h
PaperDe novo design of picomolar SARS-CoV-2 miniprotein inhibitors. | Cao L, Goreshnik I, Coventry B, Case JB, Miller L, Kozodoy L, Chen RE, Carter L, Walls AC, Park YJ, Strauch EM, Stewart L, Diamond MS, Veesler D, Baker D. | Science. 2020 Oct 23;370(6515):426-431. | DOI:10.1126/science.abd9909 | PMID:32907861 PMID32907861 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/32907861/
RECORD: Rec_0343377 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Miniprotein inhibitor
9606
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral
Severe acute respiratory syndrome coronavirus 2
0.00002354 μM
IC50
PaperDe novo design of picomolar SARS-CoV-2 miniprotein inhibitors PMID32907861 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/32907861/